Abiopharma

🔍 Gibson Christopher (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2025-08-26

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Class A Common Stock (Direct)
  Date: 2025-08-26 | Code: C | equity_swap_involved: 0 | shares_owned_after: 1,054,229.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 100,000 shares of Class A Common Stock at $4.84 per share (Direct)
  Date: 2025-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 954,229.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 100,000 shares of Class B Common Stock (Derivative)
  Date: 2025-08-26 | Code: C | equity_swap_involved: 0 | shares_owned_after: 5,373,034.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Holds 386,000 shares of Class B Common Stock (Derivative)
  Date: 2025-08-26 | Code: H | shares_owned_after: 386,000.00 | Footnotes: F1, F1, F3
• Holds 50,000 shares of Class B Common Stock (Derivative)
  Date: 2025-08-26 | Code: H | shares_owned_after: 50,000.00 | Footnotes: F1, F1, F4
• Holds 0 shares of Class B Common Stock (Derivative)
  Date: 2025-08-26 | Code: H | shares_owned_after: 388,000.00 | Footnotes: F1, F1, F5
• Holds 0 shares of Stock Option (Right to Buy) at $7.25 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2035-02-03 | shares_owned_after: 1,050,567.00 | Footnotes: F6
• Holds 0 shares of Stock Option (Right to Buy) at $10.09 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2034-02-09 | shares_owned_after: 666,898.00 | Footnotes: F7
• Holds 0 shares of Stock Option (Right to Buy) at $8.55 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2033-02-01 | shares_owned_after: 813,600.00 | Footnotes: F8
• Holds 0 shares of Stock Option (Right to Buy) at $11.4 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2032-02-04 | shares_owned_after: 399,002.00 | Footnotes: F9
• Holds 0 shares of Stock Option (Right to Buy) at $11.4 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2032-02-04 | Exercise: 2022-02-04 | shares_owned_after: 5,436.00
• Holds 0 shares of Stock Option (Right to Buy) at $2.48 per share (Derivative)
  Date: 2025-08-26 | Code: H | Expires: 2030-12-30 | shares_owned_after: 282,500.00 | Footnotes: F10

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
• F2: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
• F3: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
• F4: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
• F5: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
• F6: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
• F7: The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
• F8: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
• F9: The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
• F10: The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.